|
1
|
Liu YZ, Wang YX and Jiang CL:
Inflammation: The common pathway of stress-related diseases. Front
Hum Neurosci. 11(316)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR
and Yang SM: Macrophages in tumor microenvironments and the
progression of tumors. Clin Dev Immunol.
2012(948098)2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gordon S and Martinez FO: Alternative
activation of macrophages: Mechanism and functions. Immunity.
32:593–604. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Orecchioni M, Ghosheh Y, Pramod AB and Ley
K: Macrophage polarization: Different gene signatures in M1(LPS+)
vs. classically and M2(LPS-) vs. alternatively activated
macrophages. Front Immunol. 10(1084)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shapouri-Moghaddam A, Mohammadian S,
Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi
A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization,
and function in health and disease. J Cell Physiol. 233:6425–6440.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Takeuchi O and Akira S: Pattern
recognition receptors and inflammation. Cell. 140:805–820.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mantovani A, Sica A, Sozzani S, Allavena
P, Vecchi A and Locati M: The chemokine system in diverse forms of
macrophage activation and polarization. Trends Immunol. 25:677–686.
2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bluguermann C, Wu L, Petrigliano F,
McAllister D, Miriuka S and Evseenko DA: Novel aspects of
parenchymal-mesenchymal interactions: From cell types to molecules
and beyond. Cell Biochem Funct. 31:271–280. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Saleh M, Vaezi AA, Aliannejad R,
Sohrabpour AA, Kiaei SZF, Shadnoush M, Siavashi V, Aghaghazvini L,
Khoundabi B, Abdoli S, et al: Cell therapy in patients with
COVID-19 using Wharton's jelly mesenchymal stem cells: A phase 1
clinical trial. Stem Cell Res Ther. 12(410)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Forbes GM, Sturm MJ, Leong RW, Sparrow MP,
Segarajasingam D, Cummins AG, Phillips M and Herrmann RP: A Phase 2
study of allogeneic mesenchymal stromal cells for luminal Crohn's
disease refractory to biologic therapy. Clin Gastroenterol Hepatol.
12:64–71. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liang J, Zhang H, Hua B, Wang H, Lu L, Shi
S, Hou Y, Zeng X, Gilkeson GS and Sun L: Allogenic mesenchymal stem
cells transplantation in refractory systemic lupus erythematosus: A
pilot clinical study. Ann Rheum Dis. 69:1423–1429. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liang L, Li Z, Ma T, Han Z, Du W, Geng J,
Jia H, Zhao M, Wang J, Zhang B, et al: Transplantation of human
placenta-derived mesenchymal stem cells alleviates critical limb
ischemia in diabetic Nude rats. Cell Transplant. 26:45–61.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hu Y, Liao L, Wang Q, Ma L, Ma G, Jiang X
and Zhao RC: Isolation and identification of mesenchymal stem cells
from human fetal pancreas. J Lab Clin Med. 141:342–349.
2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tsai MS, Lee JL, Chang YJ and Hwang SM:
Isolation of human multipotent mesenchymal stem cells from
second-trimester amniotic fluid using a novel two-stage culture
protocol. Hum Reprod. 19:1450–1456. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL
and Chen TH: Isolation of multipotent mesenchymal stem cells from
umbilical cord blood. Blood. 103:1669–1675. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng
YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD and Yoo TJ:
Administering human adipose-derived mesenchymal stem cells to
prevent and treat experimental arthritis. Clin Immunol.
141:328–337. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xiang E, Han B, Zhang Q, Rao W, Wang Z,
Chang C, Zhang Y, Tu C, Li C and Wu D: Human umbilical cord-derived
mesenchymal stem cells prevent the progression of early diabetic
nephropathy through inhibiting inflammation and fibrosis. Stem Cell
Res Ther. 11(336)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wu Q, Fang T, Lang H, Chen M, Shi P, Pang
X and Qi G: Comparison of the proliferation, migration and
angiogenic properties of human amniotic epithelial and mesenchymal
stem cells and their effects on endothelial cells. Int J Mol Med.
39:918–926. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang
Y, Si Y, Guo Y, Zang L, Mu Y and Han W: Human umbilical
cord-derived mesenchymal stem cells elicit macrophages into an
anti-inflammatory phenotype to alleviate insulin resistance in type
2 diabetic rats. Stem Cells. 34:627–639. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pelekanos RA, Sardesai VS, Futrega K, Lott
WB, Kuhn M and Doran MR: Isolation and expansion of mesenchymal
stem/stromal cells derived from human placenta tissue. J Vis Exp.
(112)(54204)2016.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Li JY, Ren KK, Zhang WJ, Xiao L, Wu HY,
Liu QY, Ding T, Zhang XC, Nie WJ, Ke Y, et al: Human amniotic
mesenchymal stem cells and their paracrine factors promote wound
healing by inhibiting heat stress-induced skin cell apoptosis and
enhancing their proliferation through activating PI3K/AKT signaling
pathway. Stem Cell Res Ther. 10(247)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Biswas SK, Chittezhath M, Shalova IN and
Lim JY: Macrophage polarization and plasticity in health and
disease. Immunol Res. 53:11–24. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Randolph GJ, Jakubzick C and Qu C: Antigen
presentation by monocytes and monocyte-derived cells. Curr Opin
Immunol. 20:52–60. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Duffield JS: The inflammatory macrophage:
A story of Jekyll and Hyde. Clin Sci (Lond). 104:27–38.
2003.PubMed/NCBI
|
|
27
|
Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y,
Guo M, Xie Y, Meng J, Zhang H, et al: Targeting the shift from M1
to M2 macrophages in experimental autoimmune encephalomyelitis mice
treated with fasudil. PloS One. 8(e54841)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bowdridge S and Gause WC: Regulation of
alternative macrophage activation by chromatin remodeling. Nat
Immunol. 11:879–881. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen H, Sun H, You F, Sun W, Zhou X, Chen
L, Yang J, Wang Y, Tang H, Guan Y, et al: Activation of STAT6 by
sting is critical for antiviral innate immunity. Cell. 147:436–446.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Odegaard JI, Ricardo-Gonzalez RR, Goforth
MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D,
Brombacher F, Ferrante AW and Chawla A: Macrophage-specific
PPARgamma controls alternative activation and improves insulin
resistance. Nature. 447:1116–1120. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fujisaka S, Usui I, Kanatani Y, Ikutani M,
Takasaki I, Tsuneyama K, Tabuchi Y, Bukhari A, Yamazaki Y, Suzuki
H, et al: Telmisartan improves insulin resistance and modulates
adipose tissue macrophage polarization in high-fat-fed mice.
Endocrinology. 152:1789–1799. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kim J and Hematti P: Mesenchymal stem
cell-educated macrophages: A novel type of alternatively activated
macrophages. Exp Hematol. 37:1445–1453. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kwon JH, Kim M, Bae YK, Kim GH, Choi SJ,
Oh W, Um S and Jin HJ: Decorin secreted by human umbilical cord
blood-derived mesenchymal stem cells induces macrophage
polarization via CD44 to repair hyperoxic lung injury. Int J Mol
Sci. 20(4815)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lu YC, Yeh WC and Ohashi PS: LPS/TLR4
signal transduction pathway. Cytokine. 42:145–151. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kollarova J, Cenk E, Schmutz C and Marko
D: The mycotoxin alternariol suppresses lipopolysaccharide-induced
inflammation in THP-1 derived macrophages targeting the NF-κB
signalling pathway. Arch Toxicol. 92:3347–3358. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer.
12(86)2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wesche DE, Lomas-Neira JL, Perl M, Chung
CS and Ayala A: Leukocyte apoptosis and its significance in sepsis
and shock. J Leukoc Biol. 78:325–337. 2005.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Brown MA and Jones WK: NF-kappaB action in
sepsis: The innate immune system and the heart. Front Biosci.
9:1201–1217. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Liu Y, Liu L, Zhou Y, Zhou P, Yan Q, Chen
X, Ding S and Zhu F: CKLF1 enhances inflammation-mediated
carcinogenesis and prevents doxorubicin-induced apoptosis via
IL6/STAT3 Signaling in HCC. Clin Cancer Res. 25:4141–4154.
2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Isik A, Isik N and Kurnaz E: Complete
breast autoamputation: Clinical image. Breast J. 26:2265–2266.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Isik A, Soran A, Grasi A, Barry N and
Sezgin E: Lymphedema after sentinel lymph node biopsy: Who is at
Risk? Lymphat Res Biol. 20:160–163. 2022.PubMed/NCBI View Article : Google Scholar
|
